ATE321892T1 - Hiv-nachweisverfahren und reagenzien dafür - Google Patents
Hiv-nachweisverfahren und reagenzien dafürInfo
- Publication number
- ATE321892T1 ATE321892T1 AT01921607T AT01921607T ATE321892T1 AT E321892 T1 ATE321892 T1 AT E321892T1 AT 01921607 T AT01921607 T AT 01921607T AT 01921607 T AT01921607 T AT 01921607T AT E321892 T1 ATE321892 T1 AT E321892T1
- Authority
- AT
- Austria
- Prior art keywords
- assays
- methods
- reagents
- virus
- viral
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0009374.0A GB0009374D0 (en) | 2000-04-14 | 2000-04-14 | Phenotyping assay and reagents therefor |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE321892T1 true ATE321892T1 (de) | 2006-04-15 |
Family
ID=9890016
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01921607T ATE321892T1 (de) | 2000-04-14 | 2001-04-12 | Hiv-nachweisverfahren und reagenzien dafür |
Country Status (8)
Country | Link |
---|---|
US (1) | US20040038199A1 (de) |
EP (1) | EP1272676B1 (de) |
AT (1) | ATE321892T1 (de) |
AU (1) | AU4857801A (de) |
DE (1) | DE60118351T2 (de) |
ES (1) | ES2260212T3 (de) |
GB (1) | GB0009374D0 (de) |
WO (1) | WO2001079542A2 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2244332B1 (es) * | 2004-05-10 | 2007-02-16 | Fundacion Para La Investigacion Y La Prevencion Del Sida En España | Nuevos clones virales recombinantes basados en vih y su utilizacion en metodos analiticos. |
EP2010680A2 (de) * | 2006-04-14 | 2009-01-07 | Tibotec Pharmaceuticals Ltd. | Verfahren und mittel zur beurteilung von hiv-gag-/proteasehemmer-therapie |
GB0701253D0 (en) | 2007-01-23 | 2007-02-28 | Diagnostics For The Real World | Nucleic acid amplification and testing |
AU2010247444A1 (en) * | 2009-05-12 | 2011-11-24 | Virco Bvba | HIV-1-C resistance monitoring |
CN114574521B (zh) * | 2022-03-03 | 2023-09-12 | 山东中医药大学 | 一种基于平衡补偿的重组流感病毒构建方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2177922T3 (es) * | 1996-01-26 | 2002-12-16 | Virco Bvba | Metodo de valoracion la quimioterapia de pacientes hiv-positivos basado en la sensibilidad fenotipica a los farmacos de las cepas de hiv delpaciente. |
GB9909793D0 (en) * | 1999-04-28 | 1999-06-23 | Glaxo Group Ltd | Improved assay and reagents therefor |
MXPA01012270A (es) * | 1999-05-28 | 2003-06-24 | Virco Nv | Nuevos perfiles mutacionales en la transcriptasa reversa de vih-1 correlacionadas con resistencia fenotipica a farmacos. |
EP1109019A1 (de) * | 1999-12-15 | 2001-06-20 | BioStrands S.r.l. | Verfahren zur Ermittlung der Empfindlichkeit von HIV-Varianten gegen Hemmstoffe der HIV-Protease |
AU2001233513A1 (en) * | 2000-02-04 | 2001-08-14 | K.U. Leuven Research And Development | Hiv-1 resistance assay |
-
2000
- 2000-04-14 GB GBGB0009374.0A patent/GB0009374D0/en not_active Ceased
-
2001
- 2001-04-12 AT AT01921607T patent/ATE321892T1/de not_active IP Right Cessation
- 2001-04-12 WO PCT/GB2001/001728 patent/WO2001079542A2/en active IP Right Grant
- 2001-04-12 US US10/257,607 patent/US20040038199A1/en not_active Abandoned
- 2001-04-12 DE DE60118351T patent/DE60118351T2/de not_active Revoked
- 2001-04-12 ES ES01921607T patent/ES2260212T3/es not_active Expired - Lifetime
- 2001-04-12 EP EP01921607A patent/EP1272676B1/de not_active Revoked
- 2001-04-12 AU AU48578/01A patent/AU4857801A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20040038199A1 (en) | 2004-02-26 |
DE60118351T2 (de) | 2006-11-30 |
DE60118351D1 (de) | 2006-05-18 |
WO2001079542A2 (en) | 2001-10-25 |
EP1272676A2 (de) | 2003-01-08 |
EP1272676B1 (de) | 2006-03-29 |
GB0009374D0 (en) | 2000-05-31 |
AU4857801A (en) | 2001-10-30 |
ES2260212T3 (es) | 2006-11-01 |
WO2001079542A3 (en) | 2002-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Thomson et al. | Comparison of next-generation sequencing technologies for comprehensive assessment of full-length hepatitis C viral genomes | |
Popper et al. | Low plasma human immunodeficiency virus type 2 viral load is independent of proviral load: low virus production in vivo | |
Mangeat et al. | A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to Vif action | |
Resch et al. | Nelfinavir-resistant, amprenavir-hypersusceptible strains of human immunodeficiency virus type 1 carrying an N88S mutation in protease have reduced infectivity, reduced replication capacity, and reduced fitness and process the Gag polyprotein precursor aberrantly | |
ATE282720T1 (de) | Nukleinsäuresequenzen als primer und sonden zur amplifizierung und erkennung von allen hiv-1 subtypen | |
Oelrichs et al. | The explosive human immunodeficiency virus type 1 epidemic among injecting drug users of Kathmandu, Nepal, is caused by a subtype C virus of restricted genetic diversity | |
Albertoni et al. | Mini review: current molecular methods for the detection and quantification of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1 | |
Contreras-Galindo et al. | A new Real-Time-RT-PCR for quantitation of human endogenous retroviruses type K (HERV-K) RNA load in plasma samples: increased HERV-K RNA titers in HIV-1 patients with HAART non-suppressive regimens | |
Gryadunov et al. | Hepatitis C virus genotyping using an oligonucleotide microarray based on the NS5B sequence | |
Huang et al. | dsmCRISPR: Dual synthetic mismatches CRISPR/Cas12a-based detection of SARS-CoV-2 D614G mutation | |
Shang et al. | Development and validation of an efficient in-house real-time reverse transcription polymerase chain reaction assay for the quantitative detection of serum hepatitis delta virus RNA in a diverse South London population | |
Puig et al. | Sensitivity and reproducibility of HCV quantitation in chimpanzee sera using TaqMan real-time PCR assay | |
Sherpa et al. | Evolution of the HIV-1 rev response element during natural infection reveals nucleotide changes that correlate with altered structure and increased activity over time | |
Sam et al. | Validation of a solid-phase electrochemical array for genotyping hepatitis C virus | |
WO2000066774A3 (en) | Improved assay and reagents therefor | |
Lu et al. | Evolution of resistant M414T mutants among hepatitis C virus replicon cells treated with polymerase inhibitor A-782759 | |
Shuck-Lee et al. | Single-nucleotide changes in the HIV Rev-response element mediate resistance to compounds that inhibit Rev function | |
ATE321892T1 (de) | Hiv-nachweisverfahren und reagenzien dafür | |
Grohman et al. | An immature retroviral RNA genome resembles a kinetically trapped intermediate state | |
Wei et al. | Simple subtyping assay for human immunodeficiency virus type 1 subtypes B, C, CRF01-AE, CRF07-BC, and CRF08-BC | |
BRPI0413825A (pt) | detecção molecular multialélica de coronavìrus associado com sars | |
Lu et al. | Virus–host mucosal interactions during early SIV rectal transmission | |
Ganova-Raeva et al. | Detection of hepatitis C virus transmission by use of DNA mass spectrometry | |
Wilber | Branched DNA for quantification of viral load | |
Müller et al. | A novel internally controlled real-time reverse transcription-PCR assay for HIV-1 RNA targeting the pol integrase genomic region |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |